Dr. Richard Jeremy Stone is the Founder, Chief Executive Officer, and Chairman of EERO, an infrastructure platform he has funded since its inception four years ago. EERO represents the ultimate culmination of his multi-decade career focused on industrial efficiency, human-scale design, and sustainable travel. Over a 35-year professional trajectory, Dr. Stone has operated at the intersection of international aviation structured finance, deep tech venture capital, large-scale infrastructure, sustainability, corporate management, and aerospace medicine.

Dr. Stone’s aviation expertise spans roles as a pilot, asset lessor, and owner/operator of multiple Air Operator Certificates (AOCs). As Chairman and principal owner of Orbis Capital, a London-based aviation structured finance bank later acquired by Merlin Ventures, he developed a deep understanding of heavy asset architecture. He subsequently owned and operated Veritair - a tactical helicopter operator serving the BBC, police, and military - which was sold to Sir Peter Rigby’s aviation group. Under his ownership in the mid-2000s, Veritair became the first European AOC to pioneer retiring emissions through a voluntary carbon credit scheme (under the HeliLux Carbon Neutral Flights brand). This anchored a 20-year involvement in the Sustainable Aviation Fuel (SAF) space, where his focus has centered on exploring alternative feedstocks (including Kenaf) and advanced thermochemical processing technologies, specifically pyrolysis and catalysis.

In infrastructure and sustainability, Dr. Stone has focused on scaling capital-efficient solutions for high-emission sectors. He founded Mootral, an early leader in aviation-focused methane reduction that pioneered the "Cow Credit" project (later sold to Zaluvida), and served as CFO and Chief Science Officer of Hyperloop TT. His operational background includes founding and co-leading commercial airline start-ups and turnarounds across both low-cost carrier (LCC) and business-class-only models. Additionally, he served for many years on the Board of GX Design Engineers, guiding the firm through a successful management buyout (MBO). He is the founder of Project Whittle, a jet fuel burn reduction and efficiency project, exploring US military airframe performance gains.

Melding his aviation expertise with civic infrastructure and public heritage, Dr. Stone created and led Project Britannia - a high-profile initiative to preserve the decommissioned HMS Ark Royal for the nation. He proposed converting the aircraft carrier into a combined helipad, veterans housing complex, and maritime museum anchored at Peruvian Wharf, adjacent to Canary Wharf, ahead of the 2012 London Olympics. Navigating a complex web of public and private stakeholders, the project secured the formal support of the Royal Navy, Number 10, the Ministry of Defence, the Port of London Authority, the CAA, and Canary Wharf, before the initiative was ultimately refused by the London Mayor's Office in favor of a municipal cable car system.

In the institutional investment and corporate sectors, Dr. Stone has a proven track record of driving liquidity events. Alongside Charles and Sandy Schwab and family, he was a co-founding partner of Lattice Strategies, an investment firm acquired by The Hartford in 2014, and his family were co-founding shareholders of Admiral Insurance (LSE: ADM). He also served as President and CEO of Snyder (Ventiv) Healthcare, co-leading the company to its NASDAQ initial public offering. A prolific venture creator in digital health and biopharma, he co-founded the eHealth portal OnMedica (backed by ICG, with Esther Dyson as Board Advisor), which co-created the UK’s premier online pharmacy, Pharmacy2U. He was a founding shareholder and Director of Cardiogeni, a stem cell biopharma company established alongside Nobel Laureate Sir Martin Evans, following an earlier tenure leading the global payer/provider strategy practice at Gemini Consulting, where he devised a novel Activity Based Costing methodology to analyse complex value chains, and created the 5Ds market entrance strategy. Based upon this work he created a new form of outcome securitisation funding mechanism to improve health outcomes and incentivise clinician behaviour whilst transferring risk to capital markets as a new form of fixed income product.

Dr. Stone's academic foundation is rooted in aerospace medicine, hemodynamics, and global critical care repatriation. Supported by prestigious national and international scholarships, he conducted doctoral research into high- and zero-gravity fluid haemodynamics by Doppler at the Centre d’Essais en Vol (Paris) and the RAF Institute of Aviation Medicine (Farnborough), publishing extensively in peer-reviewed journals. He was a final British astronaut selectee for Mission Juno and a mission specialist candidate for the European Space Agency (ESA) Hermes program (cancelled in 1992).

His academic and public appointments include serving as a faculty member at Singularity University’s Future Med (NASA Ames) and as a Visiting Professor at the University of Wales, where he chaired the Prince of Wales’s Innovation Scholarships for His Majesty the King. He served as a Magistrate and Justice of the Peace in the United Kingdom. He sat on the UK Commercial Boards of Ashoka and the NSPCC.  Dr. Stone holds an MBA from the University of Keele.

Born in Wales, Jeremy and his American wife Victoria, a scholar at St John’s College, reside in Santa Fe, New Mexico.